Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Options Grant, Equity Issue, Director Resignation

29 Apr 2015 07:00

RNS Number : 6112L
3Legs Resources plc
29 April 2015
 



 

 

 

3Legs Resources plc

 

("3Legs" or "the Company")

 

Grant of Options, Issue of Equity and Directorate Change

 

 

Following the appointment of new members of the Board and completion of the £800,000 placing on 16 February 2015, the Board has resolved to grant options to subscribe for up to 43,115,259 new ordinary shares (representing 10 per cent. of the Company's ordinary share capital as at today's date). The options are exercisable at 0.232p per share at any time up to 16 February 2021 subject to a condition that no option may be exercised if such exercise would trigger a requirement to make an offer under Rule 9 of the City Code on Takeovers and Mergers. The Board has granted 25,869,153 of the 43,115,259 options available for grant.

 

Details of the options granted to Directors of the Company are set out below.

 

Director

Options granted

Richard Armstrong

8,623,051

Colin Weinberg

8,623,051

 

 

Up to 17,246,106 of the options are reserved for future grant but no director has any interest in such options unless or until a grant is made (which will be the subject of an announcement at the relevant time).

 

 

Issue of Equity

 

The Company has issued and allotted 2,155,172 new ordinary shares of 0.025p each at a price of 0.232p per share to its joint broker, Peterhouse Corporate Finance Limited, pursuant to the terms of its engagement letter.

 

Application has been made for the new shares to be admitted to trading on AIM which is expected to occur on 5 May 2015 ("Admission"). Following Admission, there will be 433,307,762 ordinary shares of 0.025p in issue with each share carrying the right to one vote.

 

 

Directorate Change

 

The Company announces that Alexander Fraser has resigned from the Board of Directors with immediate effect. As stated in the Company's announcement dated 27 January 2015, Mr. Fraser had agreed to remain with 3Legs for a transitional period following the return of capital to shareholders to oversee the handover to the new management team.

 

Richard Armstrong commented: "We would like to thank Alex for all his help in ensuring a smooth handover and wish him well for the future."

 

 

Enquiries

 

 

3Legs Resources plc

Richard Armstrong

Tel:

07787 500221

Colin Weinberg

Tel:

07836 588504

Northland Capital Partners Limited

Tel:

0207 382 1100

(Nominated Adviser and Broker)

Matthew Johnson

Edward Hutton

Peterhouse Corporate Finance Limited

Tel:

0207 469 0934

(Joint Broker)

Lucy Williams

Duncan Vasey

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPCCUPAGQR
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.